atezolizumab,nivolumab,pembrolizumab
merck,roche,bms
['nivo', 'nivolumab', 'prosper,study', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'pembro']
#esmo22 prosper study of peri operative nivolumab in rcc null hypothesis accepted pragmatic design including advocate input pembro pfs positive but os pending
nivo and atezo negative #rccsm 
Medical oncologist from Perth - Australia. Interested in thoracic oncology, breast cancer, GUs, clinical trials, fast cars (Formula 1) and @werderbremen_en